With widespread global COVID-19 vaccine coverage, a scalable, cost-effective, and
standardized tool to ascertain post-vaccine immunity is a dire need. Neither clinical …

Quantitative measurement of SARS-CoV-2 neutralizing antibodies is highly expected to
evaluate immune status, vaccine response, and antiviral therapy. The Elecsys® Anti-SARS …

ABSTRACT The Elecsys Anti-SARS-CoV-2 immunoassay (Roche Diagnostics) was
developed to provide accurate, reliable detection of antibodies to severe acute respiratory …

Abstract The Elecsys® Anti-SARS-CoV-2 S immunoassay (Roche Diagnostics International
Ltd, Rotkreuz, Switzerland) has been developed for the detection of antibodies to the severe …

There is a critical need to understand the effectiveness of serum elicited by different SARS-
CoV-2 vaccines against SARS-CoV-2 variants. We describe the generation of reference …

Neutralizing antibodies (nAbs) are considered a valuable marker for measuring humoral
immunity against SARS-CoV-2. However, live-virus neutralization tests (NTs) require high …

Introduction We performed a multicentre evaluation of the Elecsys® Anti-SARS-CoV-2
immunoassay (Roche Diagnostics), an assay utilising a recombinant protein representing …

The presence of neutralizing antibodies against SARS-CoV-2 in a large number of people is–
besides cellular immunity–important to overcome the SARS-CoV-2 pandemic. While …

Rapid and accurate measurement of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV2)-specific neutralizing antibodies (nAbs) is paramount for monitoring immunity …

This study assesses the clinical performance of three anti‐SARS‐CoV‐2 assays, namely
EUROIMMUN anti‐SARS‐CoV‐2 nucleocapsid (IgG) ELISA, Elecsys anti‐SARS‐CoV‐2 …